YLYunqi Li

Yunqi Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yunqi Li has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Irene Roberts

    Department of Paediatrics, University of Oxford, Oxford, United Kingdom

    2 shared publications
  • Paresh Vyas

    MRC Weatherall Institute of Molecular Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

    2 shared publications
  • Adam J. de Smith

    Center for Genetic Epidemiology, Keck School of Medicine of University of Southern California

    1 shared publication
  • Adam J. de Smith

    Center for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, USA

    1 shared publication
  • Allan Ronald

    Department of Medical Microbiology and Infectious Diseases, University of Manitoba , Winnipeg , Canada

    1 shared publication
  • Angela L. Rachubinski

    Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus

    1 shared publication

Latest Publications

  • Open Access

    Genome-wide association study of somatic GATA1s mutations in newborns with Down syndrome

    by Yunqi Li, Natalina Elliott, Patricia Lein, Paresh Vyas, Irene Roberts, Adam J. de Smith

    Myeloid leukemia of Down syndrome (DS) is preceded by a transient neonatal preleukemia driven by somatic mutations in the chromosome X gene GATA1, resulting in a shorter protein isoform (GATA1s). GATA1s mutations occur at high frequency in DS, but beyond trisomy 21, risk factors for this preleukemia are unknown. We investigated whether germline genetic variation influences development of GATA1s mutations in DS. Whole-genome sequencing was performed on 434 children with DS from the Oxford DS Cohort Study previously screened for GATA1s mutations. After quality control, association tests were conducted separately for disomic autosomes, trisomic chromosome 21, and chromosome X. Regression tests were performed for mutation variant allele frequency or the binary trait (103 GATA1s-positive cases, 326 controls), adjusting for sex and ancestry-related principal components. Genetic ancestry of each participant was inferred and tested for association with GATA1s mutations. We identified 3 genome-wide significant (P < 5 × 10−8) loci associated with GATA1s mutations. However, these may be false positives because few linked variants showed evidence of association at each locus. No significant associations were detected on chromosome 21 or the GATA1 region on chromosome X. Increasing proportions of South Asian genetic ancestry were associated with an increased risk of GATA1s mutations, with each 10% increase in ancestry associated with a 1.11-fold higher risk of developing GATA1s mutations (P = .031). Our genetic epidemiology study of somatic GATA1s mutations in DS did not identify strong germ line genetic effects. The association with genetic ancestry may relate to unmeasured genetic or nongenetic effects, such as fetal exposures, and warrants further investigation.


  • Open Access

    Genome-wide association studies of Down syndrome associated congenital heart defects

    by Elizabeth R. Feldman, Yunqi Li, David J. Cutler, Tracie C. Rosser, Stephanie B. Wechsler, Lauren Sanclemente, Angela L. Rachubinski, Natalina Elliott, Paresh Vyas, Irene Roberts, et al.

    Congenital heart defects (CHDs) are the most common structural birth defect and are present in 40-50% of children born with Down syndrome (DS). To characterize the genetic architecture of DS-associated CHD, we sequenced genomes of a multiethnic group of children with DS and a CHD (n=886: atrioventricular septal defects (AVSD), n=438; atrial septal defects (ASD), n=122; ventricular septal defects (VSD), n=170; other types of CHD, n=156) and DS with a structurally normal heart (DS+NH, n=572). We performed four GWAS for common variants (MAF>0.05) comparing DS with CHD, stratified by CHD-subtype, to DS+NH controls. Although no SNP achieved genome-wide significance, multiple loci in each analysis achieved suggestive significance (p−6 ). Of these, the 1p35.1 locus (near RBBP4 ) was specifically associated with ASD risk and the 5q35.2 locus (near MSX2 ) was associated with any type of CHD. Each of the suggestive loci contained one or more plausible candidate genes expressed in the developing heart. While no SNP replicated (p−6 ) in an independent cohort of DS+CHD (DS+CHD: n=229; DS+NH: n=197), most SNPs that were suggestive in our GWASs remained suggestive when meta-analyzed with the GWASs from the replication cohort. These results build on previous work to identify genetic modifiers of DS-associated CHD.


  • Open Access

    Upregulation ofPTPRCand Interferon Response Pathways in HIV-1 Seroconverters Prior to Infection

    by Yunqi Li, Francois Lefebvre, Edith Nakku-Joloba, Allan Ronald, Glenda Gray, Guy de Bruyn, James Kiarie, Connie Celum, Mark J Cameron, Jairam R Lingappa, et al.

    HIV-1 exposed seronegative (HESN) individuals may have unique characteristics that alter susceptibility to HIV-1 infection. However, identifying truly exposed HESN is challenging. We utilized stored data and biospecimens from HIV-1 serodifferent couple cohorts, which couples’ HIV-1 exposure were quantified based on unprotected sex frequency and viral load of the partner living with HIV-1. We compared peripheral blood gene expression between 15 HESN and 18 seroconverters prior to infection. We found PTPRC (encoding CD45 antigen), and interferon-response pathways had significantly higher expression among individuals who went on to become seropositive and thus may be a signature for increased acquisition risk.